Please login to the form below

Not currently logged in
Email:
Password:

BIND Biosciences

This page shows the latest BIND Biosciences news and features for those working in and with pharma, biotech and healthcare.

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal

Will combine BIND Biosciences' tissue-targeting technology with a molecularly-targeted drug. Amgen has teamed up with nanotechnology specialist BIND Biosciences to develop a new version of one of its kinase ... Cambridge, Massachusetts-based BIND has

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Use of biomarkers in marketing

    Mark Assenti is a Senior Associate Consultant at Blue Latitude. Mark began his career in the biosciences field, studying genetics at Cardiff University.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...